Proactive Rehabilitation for Chemotherapy-Induced Peripheral Neuropathy |
| |
| Affiliation: | 1. Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA;2. St. Catherine University, Minneapolis, MN;3. School of Nursing, University of Michigan, Ann Arbor, MI;1. Faculty of Nursing, Edmonton Clinic Health Academy (ECHA), Edmonton, AB, Canada;2. Department of Biomedical Engineering, University of Alberta, Edmonton, AB, Canada;3. Medical Oncology, Alberta Health Services, Edmonton, AB, Canada;4. Division of Cardiology, University of Alberta, Edmonton, AB, Canada;5. Cardiac Rehabilitation, Division of Cardiology, University of Alberta, Edmonton, AB, Canada |
| |
| Abstract: | ObjectiveTo review assessment and management approaches for chemotherapy-induced peripheral neuropathy-related physical function deficits.Data SourcesPeer-reviewed articles from PubMed, Ovid MEDLINE, CINAHL PsycINFO, SPORTDiscus, Scopus, and key studies’ reference lists.ConclusionBrief clinical tests (eg, gait, Timed Up and Go) can screen for neuropathy-related physical function deficits. Exercise and physical therapy may be promising treatments, but the efficacy and optimal dose of such treatments for chemotherapy-induced peripheral neuropathy are unclear.Implications for Nursing PracticeScreening and assessment of neuropathy-associated physical function deficits should occur throughout neurotoxic chemotherapy treatment. If such deficits are identified, referral for rehabilitation (ie, physical or occupational therapy) and/or exercise interventions is warranted. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
